Skip to main content


  • Analytical studies at GLP and non-GLP levels
  • Development of drug formulations
  • Development and validation of analytical assays in biological matrices
  • Sample analysis and PK/PD data analysis
  • Specialized methods for nanoparticle pharmacology

More Information

This core facility is under the direction of faculty director William Zamboni, PharmD, PhD, and GLP Laboratory Director John Kagel, PhD. It is affiliated with the UNC Lineberger Comprehensive Cancer Center and the UNC Eshelman School of Pharmacy.

Main Contact

Dr. William Zamboni, phone at 919-843-6665 or email 

Additional staff member contacts:

Sara O’Neal, MS, is the laboratory manager for the Translational Oncology and Nanoparticle Drug Development (TOND2I) Lab. She is an analytical chemist and bioanalytical research specialist. (contact at 1022B Genetic Medicine Building CB 7361, 919-966-9866 or
Allison Schorzman, PhD, is the head analytical chemist for the TOND2I lab. She is a clinical pharmacology research associate. (contact at 1022A Genetic Medicine Building CB 7361, 919-966-1622 or


The TOND2I Lab: 1022A/B Genetic Medicine Building.
GLP Bioanalytical Facility: 3301 Kerr Hall
Dr. Zamboni’s Office: 1013 Genetic Medicine Building, 120 Mason Farm RD, CB 7361, UNC-Chapel Hill, Chapel Hill, NC 27599